Related Experiment Video
Updated: Jun 12, 2026

A High-content Imaging Workflow to Study Grb2 Signaling Complexes by Expression Cloning
Published on: October 30, 2012
Uptake of a cell permeable G7-18NATE contruct into cells and binding with the Grb-7-SH2 domain
Nigus D Ambaye1, Reece C C Lim, Daniel J Clayton
1Department of Biochemistry and Molecular Biology, Monash University, VIC 3800, Australia.
Abstract:
Grb7 is an adapter protein found to be overexpressed in several breast and other cancer cell types along with ErbB2. Grb7 is normally an interaction partner with focal adhesion kinase and in cancer cells also aberrantly interacts with ErbB2. It is thus implicated in the migratory and proliferative potential of cancer cells. Previous studies have shown that the phage display-derived cyclic nonphosphorylated inhibitor peptide, G7-18NATE, when linked to Penetratin, is able to interfere with the interaction of Grb7 with its upstream binding partners and to impact on both cell migration and proliferation. Here we report the synthesis of a biotinylated G7-18NATE covalently attached to just the last seven residues of Penetratin (G7-18NATE-P-Biotin). We demonstrate that this construct is taken up efficiently into MDA-MB-468 breast cancer cells and colocalizes with Grb7 in the cytoplasm. We also used isothermal titration calorimetry to determine the binding affinity of G7-18NATE-P-Biotin to the Grb7-SH2 domain, and showed that it binds with micromolar affinity (K(d) = 14.4 microM), similar to the affinity of G7-18NATE (K(d) = 35.4 microM). Together this shows that this shorter G7-18NATE-P-Biotin construct is suitable for further studies of the antiproliferative and antimigratory potential of this inhibitor.
Insights
A new peptide inhibitor, G7-18NATE-P-Biotin, effectively targets the Grb7 protein in breast cancer cells. This inhibitor shows potential for reducing cancer cell migration and proliferation.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Grb7 is an adapter protein overexpressed in breast and other cancers, interacting with ErbB2 and focal adhesion kinase.
- This interaction contributes to cancer cell migration and proliferation.
- Previous inhibitors targeting Grb7-binding partners have shown potential in impacting these processes.
Purpose of the Study:
- To synthesize and characterize a novel biotinylated peptide inhibitor, G7-18NATE-P-Biotin, targeting Grb7.
- To evaluate the cellular uptake, localization, and binding affinity of this new construct.
- To assess its suitability for further investigation into anti-cancer therapeutic potential.
Main Methods:
- Synthesis of biotinylated G7-18NATE-P-Biotin.
- Cellular uptake and colocalization studies in MDA-MB-468 breast cancer cells.
- Isothermal titration calorimetry to determine binding affinity to the Grb7-SH2 domain.
Main Results:
- G7-18NATE-P-Biotin was efficiently taken up by MDA-MB-468 cells and localized with Grb7 in the cytoplasm.
- The construct demonstrated micromolar binding affinity (K(d) = 14.4 microM) to the Grb7-SH2 domain.
- This affinity is comparable to the previously studied G7-18NATE inhibitor.
Conclusions:
- The shorter G7-18NATE-P-Biotin construct is effectively internalized by breast cancer cells.
- It binds to the Grb7-SH2 domain with significant affinity.
- This optimized inhibitor is suitable for further research on its antiproliferative and antimigratory effects in cancer.
Related Concept Videos
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical, 7TM, or...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
G-protein Coupled Receptors
G-protein Coupled Receptors
GPCR Desensitization

